Does the orphan medicinal product regulation assist or hinder access to innovative haemophilia treatment in Europe?

Haemophilia. 2014 Jul;20(4):455-8. doi: 10.1111/hae.12462. Epub 2014 May 8.

Authors

B O'Mahony¹, F Peyvandi, A Bok

Affiliation

¹ European Haemophilia Consortium, Brussels, Belgium; Irish Haemophilia Society, Haemophilia Product Selection Monitoring and Advisory Board, Ireland.

PMID: 24805888
DOI: 10.1111/hae.12462

No abstract available

Publication types

Editorial

MeSH terms

Europe
Hemophilia A / drug therapy*
Humans
Inventions*
Marketing
Orphan Drug Production* / economics
Social Control, Formal*